NAOV - NanoVibronix to Expand Product Portfolio: Introduction of PainShield Relief and Product Launch Plans

NanoVibronix, Inc. (NASDAQ: NAOV) produces UroShield and PainShield Surface Acoustic Wave Portable Ultrasonic Therapeutic Devices reported that it intends to enter the Over the Counter pain relief market with the introduction of PainShield RELIEF, a non-prescription ultrasound therapy device that delivers fast pain relief for nerve and soft tissue damage.  Brian Murphy, Chief Executive Officer of NanoVibronix Inc., commented, “Entering the OTC pain relief market with our newest product in the PainShield family significantly expands our total addressable market and opens up new opportunities for growth through several additional revenue streams. Those suffering from pain will have ready access to the device with no need for clinician prescription. Plans are under way for an official launch in the U.S. and select parts of the world and product reveal in the coming months at a number of trade shows targeting a variety of athletic interests including tennis and golf. We are targeting the specific pain relief indications and the retail channels to address them as an OTC alternative to less effective interventions. The company expects widespread availability by early to mid-2022.”

Murphy continued, “The pain relief market is flooded with products that simply mask the pain versus providing proven pain resolution. We believe the opportunities are endless with this product. Our initial entry, as well as our next generation, which is currently in development, are expected to be unique to the market, as is Surface Acoustic Wave (Low Level, Low Frequency Ultrasound) technology. Our entry into the OTC market will be preceded by submission of the final results of our Lateral Epicondylitis (Tennis Elbow) study.”

The post NanoVibronix to Expand Product Portfolio: Introduction of PainShield Relief and Product Launch Plans first appeared on Financial Buzz .

For further details see: